---
title: "Cardiac-targeted delivery strategies for advanced therapies in heart disease"
id: "pubmed-42284133"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42284133"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42284133/"
doi: "10.1093/eurheartj/ehag432"
published_at: "2026-08-24T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cardiac-targeted delivery strategies for advanced therapies in heart disease
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42284133
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42284133/)
- **DOI:** [10.1093/eurheartj/ehag432](https://doi.org/10.1093%2Feurheartj%2Fehag432)
- **Published At:** 2026-08-24T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Cardiovascular disease (CVD) is the leading global cause of death and disability; rising prevalence is driven by ageing and increasing rates of diabetes, obesity, hypertension, and hyperlipidaemia. - There is an urgent need for new treatments, but clinical efficacy of advanced therapies can be limited by **inadequate delivery to the heart**. - Established approaches such as intramyocardial injection and catheter-based intracoronary delivery are effective but require invasive procedures that limit broader clinical use. - **Cardiotropic adeno-associated virus (AAV)** vectors offer less invasive cardiac targeting but face significant challenges related to immunogenicity. - Emerging cardiac-targeting delivery platforms include **extracellular vesicles**, **microbubbles**, and **nanoparticle** systems; these have potential for delivering small molecules, biologics, nucleic acid therapeutics, and gene therapies to the heart. - Key technical limitations across platforms include delivery efficiency, off-target effects, and host immune responses. - Surface modifications, cardiac-homing peptides, membrane cloaking, and organ-targeting technologies are promising strategies to enhance cardiac specificity and therapeutic index. - Improved cardiac-targeted delivery could expand effective treatment options for a range of CVDs including **ischaemic heart disease**, **heart failure**, and cardiac arrhythmias. - The review highlights both opportunities and remaining translational barriers; overcoming immunogenicity, improving targeting precision, and increasing delivery efficiency are prerequisites for clinical impact. - Specific quantitative outcomes, comparative efficacy data, and detailed clinical trial results were not reported in the source abstract and therefore are not available here.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42284133/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42284133%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42284133/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42284133/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42284133/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/af7de7da-df5d-41c6-8de4-8c266af8ccfb/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42284133/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42284133/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42284133/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42284133%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42284133%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42284133/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42284133/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42284133/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42284133/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Silverchair Information Systems full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--academic.oup.com-images-oup_pubmed.png) Silverchair Information Systems ](https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehag432 "See full text options at Silverchair Information Systems") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42284133/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42284133/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42284133/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42284133/#abstract) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42284133/#similar) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42284133/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42284133/#mesh-terms) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42284133/#related-links) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/42284133/#grants) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42284133/#linkout) Title & authors Abstract Similar articles Publication types MeSH terms Related information Grants and funding LinkOut - more resources Review Eur Heart J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+Heart+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+Heart+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) . 2026 Aug 24;47(32):4410-4426. doi: 10.1093/eurheartj/ehag432. # Cardiac-targeted delivery of advanced medical therapies for heart disease [Xiao Liu](https://pubmed.ncbi.nlm.nih.gov/?term=Liu+X&cauthor_id=42284133)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-1 "Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-2 "National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-3 "Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore."), [Yan Miao](https://pubmed.ncbi.nlm.nih.gov/?term=Miao+Y&cauthor_id=42284133)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-1 "Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China."), [Shengjie Lu](https://pubmed.ncbi.nlm.nih.gov/?term=Lu+S&cauthor_id=42284133)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-2 "National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-3 "Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore."), [Derek J Hausenloy](https://pubmed.ncbi.nlm.nih.gov/?term=Hausenloy+DJ&cauthor_id=42284133)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-2 "National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-3 "Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-4 "Yong Loo Lin School of Medicine, National University Singapore,1E Kent Ridge Road, Singapore 119228, Singapore.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#full-view-affiliation-5 "The Hatter Cardiovascular Institute, University College London, London, UK.") Affiliations Expand ### Affiliations * 1 Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. * 2 National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore. * 3 Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore. * 4 Yong Loo Lin School of Medicine, National University Singapore,1E Kent Ridge Road, Singapore 119228, Singapore. * 5 The Hatter Cardiovascular Institute, University College London, London, UK. * PMID: **42284133** * DOI: [ 10.1093/eurheartj/ehag432 ](https://doi.org/10.1093/eurheartj/ehag432) Item in Clipboard Review # Cardiac-targeted delivery of advanced medical therapies for heart disease Xiao Liu et al. Eur Heart J. 2026. Show details Display options Display options Format Abstract PubMed PMID Eur Heart J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+Heart+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+Heart+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) . 2026 Aug 24;47(32):4410-4426. doi: 10.1093/eurheartj/ehag432. ### Authors [Xiao Liu](https://pubmed.ncbi.nlm.nih.gov/?term=Liu+X&cauthor_id=42284133)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-1 "Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-2 "National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-3 "Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore."), [Yan Miao](https://pubmed.ncbi.nlm.nih.gov/?term=Miao+Y&cauthor_id=42284133)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-1 "Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China."), [Shengjie Lu](https://pubmed.ncbi.nlm.nih.gov/?term=Lu+S&cauthor_id=42284133)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-2 "National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-3 "Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore."), [Derek J Hausenloy](https://pubmed.ncbi.nlm.nih.gov/?term=Hausenloy+DJ&cauthor_id=42284133)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-2 "National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-3 "Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-4 "Yong Loo Lin School of Medicine, National University Singapore,1E Kent Ridge Road, Singapore 119228, Singapore.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42284133/#short-view-affiliation-5 "The Hatter Cardiovascular Institute, University College London, London, UK.") ### Affiliations * 1 Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. * 2 National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore169609, Singapore. * 3 Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore. * 4 Yong Loo Lin School of Medicine, National University Singapore,1E Kent Ridge Road, Singapore 119228, Singapore. * 5 The Hatter Cardiovascular Institute, University College London, London, UK. * PMID: **42284133** * DOI: [ 10.1093/eurheartj/ehag432 ](https://doi.org/10.1093/eurheartj/ehag432) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID ## Abstract Cardiovascular diseases (CVD) are the leading causes of death and disability worldwide with their global burden on the rise due to the ageing population and escalating prevalence of CVD risk factors, such as diabetes, obesity, hypertension, and hyperlipidaemia. As such, new treatments are urgently needed to improve health outcomes in patients with CVD. However, the efficacy of emerging medical and advanced therapies for CVD may be hampered by their inadequate delivery to the heart. Established delivery strategies such as intramyocardial injection and catheter-based intracoronary delivery technologies require an invasive intervention, thereby limiting their clinical application. Although cardiotropic adeno-associated virus vectors, which target therapeutics to the heart are less invasive they have their own challenges in terms of immunogenicity. This article provides a state-of-the-art review of the recent advances in cardiac-targeting delivery systems including local intracoronary catheter-based delivery, cardiotropic adeno-associated viruses, extracellular vesicles, microbubbles, and nanoparticle delivery platforms, which have emerged as promising approaches for targeting the delivery of medical and advanced therapies such as small molecules, biologics, nucleic acid therapeutics, and gene therapies to the heart to combat CVD. However, challenges concerning immunogenicity, off-target effects, and delivery efficiency must be overcome to realize their therapeutic potential as safe and effective therapies. By leveraging surface modifications, cardiac-homing peptides, membrane cloaking, and organ-targeting technologies, the emerging cardiac-targeting delivery systems promise more effective medical and advanced therapies for a wide range of CVD, including ischaemic heart disease, heart failure, and cardiac arrhythmias. **Keywords:** Acute myocardial infarction; Adeno-associated virus; Cardiac-targeting; Extracellular vesicles; Heart failure; Nanoparticles. © The Author(s) 2026. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Similar articles * [ Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration. ](https://pubmed.ncbi.nlm.nih.gov/38392252/) Kishore R, Magadum A.Kishore R, et al.J Cardiovasc Dev Dis. 2024 Jan 26;11(2):38. doi: 10.3390/jcdd11020038.J Cardiovasc Dev Dis. 2024.PMID: 38392252Free PMC article.Review. * [ Nanoparticle-Based Therapeutic Strategies in Respiratory Diseases: Current Approaches and Future Perspectives. ](https://pubmed.ncbi.nlm.nih.gov/41340279/) Cinar O, Kimiz-Gebologlu I, Oncel SS.Cinar O, et al.Thorac Res Pract. 2025 Dec 1;26(Suppl 1):31-33. doi: 10.4274/ThoracResPract.2025.s012.Thorac Res Pract. 2025.PMID: 41340279Free PMC article. * [ Providing Access To Monoclonal Antibody Treatment Of Coronavirus (COVID-19) Patients In Rural And Underserved Areas. ](https://pubmed.ncbi.nlm.nih.gov/34662052/) Wood DA, Aleem A, Davis D.Wood DA, et al.2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.PMID: 34662052Free Books & Documents. * [ Advances in nanostructured drug delivery systems for cardiovascular therapeutics. ](https://pubmed.ncbi.nlm.nih.gov/41269573/) Saadh MJ, Allela OQB, Kareem RA, Padmapriya G, Mishra A, Kazmi SW, Prasad GVS, Sameer HN, Hamad AK, Athab ZH, Adil M.Saadh MJ, et al.Daru. 2025 Nov 21;34(1):2. doi: 10.1007/s40199-025-00581-y.Daru. 2025.PMID: 41269573Review. * [ Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease. ](https://pubmed.ncbi.nlm.nih.gov/40600550/) Hasan U, Jain H, Ali R.Hasan U, et al.Curr Drug Targets. 2025;26(11):779-798. doi: 10.2174/0113894501388678250618070927.Curr Drug Targets. 2025.PMID: 40600550Review. [ See all similar articles ](https://pubmed.ncbi.nlm.nih.gov/?linkname=pubmed_pubmed&from_uid=42284133) ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) ## MeSH terms * Dependovirus Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Dependovirus%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Dependovirus) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) * Drug Delivery Systems* / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drug+Delivery+Systems%2Fmethods%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drug+Delivery+Systems) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) * Gene Therapy Agents Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gene+Therapy+Agents%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gene+Therapy+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) * Gene Transfer Techniques Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gene+Transfer+Techniques%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gene+Transfer+Techniques) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) * Genetic Therapy / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Genetic+Therapy%2Fmethods%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Genetic+Therapy) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42284133/) * Genetic Vectors / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Genetic+Vectors%2Fadministration+and+dosage%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mes
## Related Clinical Research

- [Stopping Statins at Age 75 in Low‑Risk Adults: French Trial Found No Increase in Deaths](https://medichelpline.com/clinical-feed/stat-news-0-stopping-statins-in-people-over-75-at-low-risk-for-heart-disease-didn-t.md)
- [Neurocrine Biosciences: weighing benefit and risk for a rare-disease drug](https://medichelpline.com/clinical-feed/stat-news-2-stat-neurocrine-biosciences-and-the-delicate-balance-of-benefit-and-risk.md)
- [Intensive blood pressure control linked to 15% lower 7-year dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-intensive-blood-pressure-control-cuts-7-year-dementia-risk-by-15-study-finds.md)
- [Boost Potassium as well as Lower Sodium for Better Blood Pressure Control](https://medichelpline.com/clinical-feed/medical-news-today-0-for-better-blood-pressure-control-don-t-just-lower-salt-also-boost-potassium.md)
- [Sex and NOS inhibition shape distinct cardiac responses to cardiometabolic stress in older mice](https://medichelpline.com/clinical-feed/biorxiv-6-nitric-oxide-synthase-inhibition-and-biological-sex-define-different-cardiac.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.